Fibroblast phenylalanine concentration as a surrogate biomarker of cellular number

J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Jul 15:1226:123787. doi: 10.1016/j.jchromb.2023.123787. Epub 2023 Jun 10.

Abstract

Metabolomics studies in human dermal fibroblasts can elucidate the biological mechanisms associated with some diseases, but several methodological issues that increase variability have been identified. We aimed to quantify the amino acid levels in cultured fibroblasts and to apply different sample-based normalization approaches. Forty-four skin biopsies from control subjects were collected. Amino acids were measured in fibroblasts supernatants by UPLC-MS/MS. Statistical supervised and unsupervised studies were used. Spearman's test showed that phenylalanine displayed the second highest correlation with the remaining amino acids (mean r = 0.8), whereas the total protein concentration from the cell pellet showed a mean of r = 0.67. The lowest percentage of variation was obtained when amino acids were normalized by phenylalanine values, with a mean of 42% vs 57% when normalized by total protein values. When amino acid levels were normalized by phenylalanine, Principal Component Analysis and clustering analyses identified different fibroblasts groups. In conclusion, phenylalanine may be a suitable biomarker to estimate cellular content in cultured fibroblasts.

Keywords: Fibroblast content; Phenylalanine; Principal component analysis; Targeted metabolomics; UPLC–MS/MS.

MeSH terms

  • Amino Acids / metabolism
  • Biomarkers / metabolism
  • Chromatography, Liquid
  • Fibroblasts
  • Humans
  • Metabolomics
  • Phenylalanine* / metabolism
  • Tandem Mass Spectrometry*

Substances

  • Phenylalanine
  • Amino Acids
  • Biomarkers